Cargando…

Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects

BACKGROUND: Insulin resistance can occur in all metabolic organs including the liver, adipose tissue, and skeletal muscles. Circulating soluble epidermal growth factor receptor (soluble EGFR) and adipsin levels are altered in obese diabetic mice and are possibly correlated with insulin resistance in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kyohara, Mayu, Shirakawa, Jun, Okuyama, Tomoko, Togashi, Yu, Inoue, Ryota, Li, Jinghe, Miyashita, Daisuke, Terauchi, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526230/ https://www.ncbi.nlm.nih.gov/pubmed/33005239 http://dx.doi.org/10.1186/s13098-020-00591-7

Ejemplares similares

Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
por: Okuyama, Tomoko, et al.
Publicado: (2021)

Association between circulating SerpinB1 levels and insulin sensitivity in Japanese with type 2 diabetes: A single-center, cross-sectional, observational study
por: Kyohara, Mayu, et al.
Publicado: (2022)

Immediate Glucose-Lowering Effect After the First Administration of Dulaglutide: A Retrospective, Single-Center, Observational Study
por: Terui, Sakiko, et al.
Publicado: (2021)

Asymptomatic meningitis diagnosed by positron emission tomography in a patient with syndrome of inappropriate antidiuretic hormone secretion: a case report
por: Hasebe, Masanori, et al.
Publicado: (2021)

Abdominal aortic calcification is associated with Fibrosis‐4 index and low body mass index in type 2 diabetes patients: A retrospective cross‐sectional study
por: Togashi, Yu, et al.
Publicado: (2022)

The Roles of the IGF Axis in the Regulation of the Metabolism: Interaction and Difference between Insulin Receptor Signaling and IGF-I Receptor Signaling
por: Okuyama, Tomoko, et al.
Publicado: (2021)

Protective effects of S100A8 on sepsis mortality: Links to sepsis risk in obesity and diabetes
por: Miyashita, Daisuke, et al.
Publicado: (2022)

Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic β cell proliferation after the withdrawal of OSI-906
por: Tajima, Kazuki, et al.
Publicado: (2017)

Identification of the matricellular protein Fibulin-5 as a target molecule of glucokinase-mediated calcineurin/NFAT signaling in pancreatic islets
por: Okuyama, Tomoko, et al.
Publicado: (2017)

Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor
por: Okuyama, Tomoko, et al.
Publicado: (2020)

Evaluation of the appropriateness of using glucometers for measuring the blood glucose levels in mice
por: Togashi, Yu, et al.
Publicado: (2016)

Uncoupling protein 2 and aldolase B impact insulin release by modulating mitochondrial function and Ca(2+) release from the ER
por: Inoue, Ryota, et al.
Publicado: (2022)

DPP-4 inhibition improves early mortality, β cell function, and adipose tissue inflammation in db/db mice fed a diet containing sucrose and linoleic acid
por: Shirakawa, Jun, et al.
Publicado: (2016)

The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes
por: Inoue, Ryota, et al.
Publicado: (2021)

Physiological Roles of Adipokines, Hepatokines, and Myokines in Ruminants
por: Roh, Sang-Gun, et al.
Publicado: (2016)

Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
por: de Oliveira dos Santos, Ana Rita, et al.
Publicado: (2021)

Adipsin Is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines
por: Natarajan, Renuka, et al.
Publicado: (2015)

Influence of Timing of Insulin Initiation on Long-term Glycemic Control in Japanese Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Miyazaki, Takashi, et al.
Publicado: (2019)

FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases
por: Itoh, Nobuyuki
Publicado: (2014)

Metabolic Adaptation in Obesity and Type II Diabetes: Myokines, Adipokines and Hepatokines
por: Oh, Kyoung-Jin, et al.
Publicado: (2016)

Adipokine-myokine-hepatokine compartment-system in mothers and children: An explorative study
por: Deibert, Clara, et al.
Publicado: (2016)

Circulating Adipokines and Hepatokines Serve as Diagnostic Markers during Obesity Therapy
por: Schmid, Andreas, et al.
Publicado: (2022)

Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation
por: Ren, Yakun, et al.
Publicado: (2022)

E2F1 transcription factor mediates a link between fat and islets to promote β cell proliferation in response to acute insulin resistance
por: Shirakawa, Jun, et al.
Publicado: (2022)

Differences in Adipokine and Hepatokine Levels among Non-diabetic Population Classified by Age and Sex
por: Lee, Eun Soo, et al.
Publicado: (2013)

Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes
por: Susairaj, Priscilla, et al.
Publicado: (2021)

Editorial: The roles and mechanisms of hepatokines, adipokines and myokines in the development of non-alcoholic fatty liver disease (NAFLD)
por: Lu, Yan
Publicado: (2022)

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
por: Yang, Bing, et al.
Publicado: (2022)

Evaluation of the adipokine profile (adiponectin, resistin, adipsin, vaspin, and leptin) in patients with early rheumatoid arthritis and its correlation with disease activity
por: Magali Chamorro-Melo, Yany, et al.
Publicado: (2022)

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
por: Yang, Bing, et al.
Publicado: (2023)

Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study
por: Nakaguchi, Hirotatsu, et al.
Publicado: (2020)

The roles of hepatokine and osteokine in liver-bone crosstalk: Advance in basic and clinical aspects
por: Li, Zhanghao, et al.
Publicado: (2023)

Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies
por: Stefan, Norbert, et al.
Publicado: (2014)

The Hepatokine Adropin Is Regulated by Estrogen
por: Stokar, Joshua, et al.
Publicado: (2021)

Serum Adipsin Levels throughout Normal Pregnancy and Preeclampsia
por: Poveda, Natalia E., et al.
Publicado: (2016)

Regulation of Adipsin Expression by Endoplasmic Reticulum Stress in Adipocytes
por: Ryu, Ka-Young, et al.
Publicado: (2020)

The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review
por: Gonzalez-Gil, Adrian M., et al.
Publicado: (2020)

Hepatokines as a Molecular Transducer of Exercise
por: Seo, Dae Yun, et al.
Publicado: (2021)

Circulating adipsin is associated with asymptomatic carotid atherosclerosis in obese adults
por: Zhang, Jinhua, et al.
Publicado: (2021)

Increased Serum Adipsin Correlates with MAFLD and Metabolic Risk Abnormalities
por: Pan, Jie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rvk58ammte1qk27tdvnocnoa33